BMJ Open · 2017 · 45 citations · 12 references
MedicineInternal MedicineNephrologyCritical Care PharmacologyRenal PathophysiologySepsisAcute Kidney InjuryIntensive Care MedicineRenal DiseaseRenal Function TestsAcute Kidney Injury AssessmentAcute Kidney Injury DiagnosisAcute Kidney Injury Risk PredictionAcute Kidney Injury StagingClinical Biomarker ValidationNeutrophil Gelatinase-associated LipocalinOptimal Threshold SelectionPositive Predictive Value
OBJECTIVES: To determine the optimal threshold of blood and urine neutrophil gelatinase-associated lipocalin (NGAL) to predict moderate to severe acute kidney injury (AKI) and persistent moderate to severe AKI lasting at least 48 consecutive hours, as defined by an adjudication panel. METHODS: A multicentre prospective observational study enrolled intensive care unit (ICU) patients and recorded daily ethylenediaminetetraacetic acid (EDTA) plasma, heparin plasma and urine NGAL. We used natural log-transformed NGAL in a logistic regression model to predict stage 2/3 AKI (defined by Kidney Disease International Global Organization). We performed the same analysis using the NGAL value at the start of persistent stage 2/3 AKI. RESULTS: Of 245 subjects, 33 (13.5%) developed stage 2/3 AKI and 25 (10.2%) developed persistent stage 2/3 AKI. Predicting stage 2/3 AKI revealed the optimal NGAL cutoffs in EDTA plasma (142.0 ng/mL), heparin plasma (148.3 ng/mL) and urine (78.0 ng/mL) and yielded the following decision statistics: sensitivity (SN)=78.8%, specificity (SP)=73.0%, positive predictive value (PPV)=31.3%, negative predictive value (NPV)=95.7%, diagnostic accuracy (DA)=73.8% (EDTA plasma); SN=72.7%, SP=73.8%, PPV=30.4%, NPV=94.5%, DA=73.7% (heparin plasma); SN=69.7%, SP=76.8%, PPV=32.9%, NPV=94%, DA=75.8% (urine). The optimal NGAL cutoffs to predict persistent stage 2/3 AKI were similar: 148.3 ng/mL (EDTA plasma), 169.6 ng/mL (heparin plasma) and 79.0 ng/mL (urine) yielding: SN=84.0%, SP=73.5%, PPV=26.6%, NPV=97.6, DA=74.6% (EDTA plasma), SN=84%, SP=76.1%, PPV=26.8%, NPV=96.5%, DA=76.1% (heparin plasma) and SN=75%, SP=75.8%, PPV=26.1, NPV=96.4%, DA=75.7% (urine). CONCLUSION: Blood and urine NGAL predicted stage 2/3 AKI, as well as persistent 2/3 AKI in the ICU with acceptable decision statistics using a single cut point in each type of specimen.
12
KDIGO Clinical Practice Guidelines for Acute Kidney Injury
Arif Khwaja · Nephron Clinical Practice · 2012 · 8K citations
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
Kianoush Kashani, Ali Al‐Khafaji, Thomas Ardiles et al. · Critical Care · 2013 · 1.4K citations · Full text
Medicine, Cell Biology, Nephrology +14
Thomas L. Nickolas, Matthew O’Rourke, Jun Yang et al. · Annals of Internal Medicine · 2008 · 680 citations
Peter A. McCullough, Andrew Shaw, Michael Haase et al. · Contributions to nephrology · 2013 · 246 citations
Medicine, Nephrology, Dialysis +16